93 results
Page 2 of 5
8-K
EX-99.1
sa9ak4ub7gnm9kn
22 Jan 24
Regulation FD Disclosure
8:01am
8-K
EX-99.2
cviccsbijw56mbi3
8 Jan 24
NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors
8:21am
424B3
8x0u7adjy a9
19 Dec 23
Prospectus supplement
4:36pm
F-3
EX-1.2
a7ljf b5gam9ady0ukjt
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-4.2
m8zra xn5
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-5.2
k4q 99i5o6t2
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-4.1
6g5d72o2jzr2nyt556
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
qja74
7 Dec 23
Shelf registration (foreign)
4:16pm
6-K
EX-99.1
mk1cdns
25 Sep 23
Current report (foreign)
8:10am
424B3
p4meky i4fgqfoo
15 Aug 23
Prospectus supplement
4:52pm
6-K
EX-99.2
y9js el2t63gq5
14 Aug 23
NewAmsterdam Pharma Announces Appointment of William “BJ” Jones, formerly of Biohaven Pharmaceuticals, as Chief Commercial Officer
4:52pm
POS AM
wd1c25bmd nwy1odm
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
6-K
EX-99.1
thn5xwuaqrwxncti
7 Aug 23
Research and development expenses
7:24am
6-K
EX-99.2
ljutrel
7 Aug 23
Research and development expenses
7:24am
424B3
ol9ue5 gp15npt
9 Jun 23
Prospectus supplement
9:43pm
6-K
EX-1.1
qqrlu9fvekthu8re44e
9 Jun 23
Current report (foreign)
9:39pm
424B3
yihkv
8 Jun 23
Prospectus supplement
5:01pm
424B3
fvrn1py3 i64o
6 Jun 23
Prospectus supplement
4:20pm
6-K
EX-99.3
2zlvlz64
5 Jun 23
Current report (foreign)
8:50am
424B3
i03osgwxp8y 6qotf
25 Apr 23
Prospectus supplement
8:14am